School of Mental Health and Psychological Science, Anhui Medical University, Hefei, China.
Clinical Laboratory, Jiamusi Hospital of traditional Chinese Medicine, Jiamusi, China.
Ann Palliat Med. 2021 Jul;10(7):7596-7612. doi: 10.21037/apm-21-1212.
Mindfulness-based interventions (MBIs) and cognitive behavioral therapy (CBT) have both been shown to be effective treatment approaches for anxiety. The purpose of this paper was to directly investigate the ability of MBIs and CBT to improve anxiety symptoms (primary outcome), as well as depression symptoms and sleep quality (second outcome).
We searched the following electronic databases from 1st December, 2019 to 14th January 2021: English databases including PubMed, PsycINFO, Web of Science, the Cochrane Library, Elsevier, Springer Link, Wiley Online Library, ClinicalTrails, and Embase, and Chinese database including CNKI, WANFANG, and CQVIP. The eligibility criteria included the following: (I) patients with anxiety disorders or symptoms of anxiety; and those with physical or mental disorders with comorbid anxiety symptoms; (II) randomized controlled trial (RCT) design; (III) the treatment group received MBIs; (IV) the control group received CBT; and (V) the treatment outcomes were anxiety, depression, and sleep quality.
In total, 4,095 abstracts were reviewed. Of these, the full-texts of 45 articles were read in detail; and 11 RCTs were finally included in the analysis. Upon completion of MBIs and CBT group sessions, the study outcomes (mean anxiety, depression, and sleep quality scores) revealed no difference between MBIs and CBT with regards to anxiety, depression, and sleep quality post-intervention. Subgroup analysis was also performed, and the results indicated that MBIs may provide a small advantage for people with anxiety symptoms compared to CBT [standard mean difference (SMD): -0.36, 95% confidence interval (CI): -0.66 to -0.06], while the CBT group demonstrated a small comparative advantage for anxiety in the Liebowitz Social Anxiety Scale (LSAS) and Social Phobia Inventory (SPIN) scales, as well as mindfulness-based stress reduction (MBSR) in the types of MBIs (LSAS: SMD: 0.35, 95% CI: 0.08 to 0.63; SPIN: SMD: 0.51, 95% CI: 0.11 to 0.92; MBSR: SMD: 0.41, 95% CI: 0.07 to 0.74).
There was no significant difference between MBIs and CBT in terms of the treatment outcomes of anxiety, depression, and sleep quality. MBIs could be used as an alternative intervention to CBT for anxiety symptoms.
This meta-analysis was conducted in line with the PRISMA guideline and was registered at PROSPERO https://www.crd.york.ac.uk/PROSPERO/ (CRD42021219822).
正念干预(MBI)和认知行为疗法(CBT)已被证明是治疗焦虑的有效方法。本文旨在直接研究 MBI 和 CBT 改善焦虑症状(主要结局)以及抑郁症状和睡眠质量(次要结局)的能力。
我们于 2019 年 12 月 1 日至 2021 年 1 月 14 日检索了以下电子数据库:包括 PubMed、PsycINFO、Web of Science、Cochrane 图书馆、Elsevier、Springer Link、Wiley Online Library、ClinicalTrails 和 Embase 的英文数据库,以及包括中国知网、万方、维普的中文数据库。纳入标准包括:(I)患有焦虑障碍或焦虑症状的患者;以及患有合并焦虑症状的躯体或精神障碍的患者;(II)随机对照试验(RCT)设计;(III)治疗组接受 MBI;(IV)对照组接受 CBT;以及(V)治疗结局为焦虑、抑郁和睡眠质量。
共审查了 4095 篇摘要。其中,详细阅读了 45 篇文章的全文;最终纳入了 11 项 RCT 进行分析。完成 MBI 和 CBT 组的疗程后,研究结局(焦虑、抑郁和睡眠质量的平均评分)显示,MBI 和 CBT 对干预后焦虑、抑郁和睡眠质量无差异。还进行了亚组分析,结果表明 MBI 可能对焦虑症状患者比 CBT 有小的优势[标准均数差(SMD):-0.36,95%置信区间(CI):-0.66 至-0.06],而 CBT 组在 Liebowitz 社交焦虑量表(LSAS)和社交恐惧症量表(SPIN)以及正念减压(MBSR)的焦虑方面表现出较小的比较优势,MBI 类型(LSAS:SMD:0.35,95%CI:0.08 至 0.63;SPIN:SMD:0.51,95%CI:0.11 至 0.92;MBSR:SMD:0.41,95%CI:0.07 至 0.74)。
MBI 和 CBT 在焦虑、抑郁和睡眠质量的治疗结局方面没有显著差异。MBI 可以作为 CBT 治疗焦虑症状的替代干预措施。
本荟萃分析符合 PRISMA 指南,并在 PROSPERO 进行注册 https://www.crd.york.ac.uk/PROSPERO/(CRD42021219822)。